| Company Name: |
Tocopharm Co., Ltd.
|
| Tel: |
+86-021-69895597 13776836200 +86-13776836200 |
| Email: |
tocopharm@gmail.com |
| Products Intro: |
Product Name:3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-
CAS:1346603-25-5
|
| Company Name: |
Roark Standards
|
| Tel: |
0755-83552066 15986688328 |
| Email: |
service@roarkstandards.com |
| Products Intro: |
Product Name:(4R,7R)-Moxifloxacin Hydrochloride 1
CAS:1346603-25-5
Purity:98% HPLC Package:10MG;25MG;50MG;100MG
|
| Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
| Tel: |
15374522761 |
| Email: |
3003392093@qq.com |
| Products Intro: |
Product Name:Moxifloxacin Impurity 25 (Mixture of enantiomers)
CAS:1346603-25-5
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Shenzhen SUNGENING Bio-Medical Co., Ltd.
|
| Tel: |
0755-28967200 13631290199 |
| Email: |
wxf@sungening.com |
| Products Intro: |
Product Name:Moxifloxacin Impurity 5
CAS:1346603-25-5
Purity:99% HPLC or More Package:10MG;25MG;50MG;100MG
|
|
| | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- Basic information |
| Product Name: | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- | | Synonyms: | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel-;(4R,7R)-Moxifloxacin Hydrochloride 1;Moxifloxacin-R-isomer Hydrochloride;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride;(4R,7R)-Moxifloxacin Hydrochloride;USP Moxifloxacin Related Compound G;Moxifloxacin USP RC G HCl;Moxifloxacin impurity 13/Moxifloxacin EP Impurity G HCl/Moxifloxacin-R-isomer HCl/ent-Moxifloxacin HCl/1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Hydrochloride | | CAS: | 1346603-25-5 | | MF: | C21H25ClFN3O4 | | MW: | 437.8923032 | | EINECS: | | | Product Categories: | | | Mol File: | 1346603-25-5.mol | ![3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- Structure](CAS/20180808/GIF/1346603-25-5.gif) |
| | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- Chemical Properties |
| solubility | DMSO (Slightly), Methanol (Slightly), Water (Slightly) | | form | Solid | | color | Pale Yellow to Light Green |
| | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- Usage And Synthesis |
| Uses | The (R,R)-Isomer of Moxifloxacin (M745000), a potential chiral degradation product of Moxifloxacin. |
| | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- Preparation Products And Raw materials |
|